Key statistics
As of last trade, PAVmed Inc (PAVM:NAQ) traded at 10.75, 79.17% above the 52 week low of 6.00 set on Jan 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 10.50 |
|---|---|
| High | 10.97 |
| Low | 10.50 |
| Bid | 10.50 |
| Offer | 11.00 |
| Previous close | 10.96 |
| Average volume | 320.97k |
|---|---|
| Shares outstanding | 995.67k |
| Free float | 820.32k |
| P/E (TTM) | 29.62 |
| Market cap | 10.91m USD |
| EPS (TTM) | -0.6822 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 14:59 GMT.
More ▼
- PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
- Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
- PAVmed Announces Reverse Stock Split
- Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
- Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
- Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
More ▼
